Low doses of cisplatin or gemcitabine plus photofrin/photodynamic therapy : disjointed cell cycle phase-related activity accounts for synergistic outcome in metastatic non-small cell lung cancer cells (H1299)
Articolo
Data di Pubblicazione:
2006
Citazione:
Low doses of cisplatin or gemcitabine plus photofrin/photodynamic therapy : disjointed cell cycle phase-related activity accounts for synergistic outcome in metastatic non-small cell lung cancer cells (H1299) / E. Crescenzi, A. Chiaviello, G. Canti, E. Reddi, B.M. Veneziani, G. Palumbo. - In: MOLECULAR CANCER THERAPEUTICS. - ISSN 1535-7163. - 5:3(2006), pp. 776-785. [10.1158/1535-7163.MCT-05-0425]
Abstract:
We compared the effects of monotherapy (photodynamic therapy or chemotherapy) versus combination therapy (photodynamic therapy plus a specific drug) on the non-small cell lung cancer cell line H1299. Our aim was to evaluate whether the additive/synergistic effects of combination treatment were such that the cytostatic dose could be reduced without affecting treatment efficacy. Photodynamic therapy was done by irradiating Photofrin-preloaded H1299 p53/p16-null cells with a halogen lamp equipped with a bandpass filter. The cytotoxic drugs used were cis-diammine-dichloroplatinum [II] (CDDP or cisplatin) and 2',2'-difluoro-2'-deoxycytidine (gemcitabine). Various treatment combinations yielded therapeutic effects (trypan blue dye exclusion test) ranging from additive to clearly synergistic, the most effective being a combination of photodynamic therapy and CDDP. To gain insight into the cellular response mechanisms underlying favorable outcomes, we analyzed the H 1299 cell cycle profiles and the expression patterns of several key proteins after monotherapy. In our conditions, we found that photodynamic therapy with Photofrin targeted G(0)-G(1) cells, thereby causing cells to accumulate in S phase. In contrast, low-dose CDDP killed cells in S phase, thereby causing an accumulation of GO-G, cells (and increased p21 expression). Like photodynamic therapy, low-dose gemcitabine targeted GO-G, cells, which caused a massive accumulation of cells in S phase (and increased cyclin A expression). Although we observed therapeutic reinforcement with both drugs and photodynamic therapy, reinforcement was more pronounced when the drug (CDDP) and photodynamic therapy exert disjointed phase-related cytotoxic activity. Thus, if photodynamic therapy is appropriately tuned, the dose of the cytostatic drug can be reduced without compromising the therapeutic response.
Tipologia IRIS:
01 - Articolo su periodico
Elenco autori:
E. Crescenzi, A. Chiaviello, G. Canti, E. Reddi, B.M. Veneziani, G. Palumbo
Link alla scheda completa: